A Bad Fit: Dan Leonard’s Leadership Style Did Not Translate At Generics Group

 
• By Derrick Gingery
  
generic exit
Dan Leonard resigned as AAM CEO on 5 December 2022. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Biosimilars & Generics